| Literature DB >> 19184539 |
Young-Min Hyun1, Craig T Lefort, Minsoo Kim.
Abstract
Although critical for cell adhesion and migration during normal immune-mediated reactions, leukocyte integrins are also involved in the pathogenesis of diverse clinical conditions including autoimmune diseases and chronic inflammation. Leukocyte integrins therefore have been targets for anti-adhesive therapies to treat the inflammatory disorders. Recently, the therapeutic potential of integrin antagonists has been demonstrated in psoriasis and multiple sclerosis. However, current therapeutics broadly affect integrin functions and, thus, yield unfavorable side effects. This review discusses the major leukocyte integrins and the anti-adhesion strategies for treating immune diseases.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19184539 PMCID: PMC2990789 DOI: 10.1007/s12026-009-8101-1
Source DB: PubMed Journal: Immunol Res ISSN: 0257-277X Impact factor: 2.829